ctDNA Detection in Microfluidic Platform: A Promising Biomarker for Personalized Cancer Chemotherapy

Figure 6

(a) Digital PCR-based microfluidic device with seven droplets to detect wild-type mutation of the KRAS oncogene [64]. (b) Micropillar-based plastic microfluidic surface to detect cfDNA; more than 90% of purities of cfDNA was extracted [69]. (c) Microcolumn- and microwell-based microfluidic for cfDNA isolation [71].

(a)

(b)

(c)